Cisplatin

Essays in Biochemistry

Volumn 34, Issue , 1999, Pages 191-211

  Trimmer, Elizabeth E ^a,b   Essigmann, John M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; NUCLEAR PROTEIN; TRANSPLATIN;

CHEMICAL STRUCTURE; CHEMISTRY; DNA ADDUCT; DNA REPAIR; DNA REPLICATION; DRUG EFFECT; DRUG RESISTANCE; GENETIC TRANSCRIPTION; HUMAN; MALE; METABOLISM; REVIEW; TESTIS TUMOR;

ANTINEOPLASTIC AGENTS; CISPLATIN; DNA ADDUCTS; DNA REPAIR; DNA REPLICATION; DRUG RESISTANCE; HUMANS; MALE; MODELS, MOLECULAR; NUCLEAR PROTEINS; TESTICULAR NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 0033287646     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/bse0340191     Document Type: Article

References (21)

1. Takahara, P.M., Frederick, C.A. & Lippard, S.J. (1996) Crystal structure of the anticancer drug cisplatin bound to duplex DNA. J. Am. Chem. Soc. 118, 12309-12321
2. Huang, H., Zhu, L., Reid, B.R., Drobny, G.P. & Hopkins, P.B. (1995) Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 270, 1842-1845
3. Brabec, V., Sip, M. & Leng, M. (1993) DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum (II). Biochemistry 32, 11676-11681
4. Keck, M.V. & Lippard, S.J. (1992) Unwinding of supercoiled DNA by platinum-ethidium and related complexes. J. Am. Chem. Soc. 114, 3386-3390
5. Corda, Y., Job, C., Anin, M-F., Leng, M. & Job, D. (1991) Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumour drug cisdiamminedichloroplatinum(II). Biochemistry 30, 222-230
6. Corda, Y., Job, C., Anin, M.-F., Leng, M. & Job, D. (1993) Spectrum of DNA-platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases. Biochemistry 32, 8582-8588
7. Mello, J.A., Lippard, S.J. & Essigmann, J.M. (1995) DNA adducts of cis-diamminedichloroplatinum (II) and its trans isomer inhibit RNA polymerase II differentially in vivo. Biochemistry 34, 14783-14791
8. Bissett, D., McLaughlin, K., Kelland, L.R. & Brown, R. (1993) Cisplatin-DNA damage recognition proteins in human tumour extracts. Br. J. Cancer 67, 742-748
9. Ohndorf, U.M., Whitehead, J.P., Raju, N.L. & Lippard, S.J. (1997) Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts. Biochemistry 36, 14807-14815
10. Trimmer, E.E., Zamble, D.B., Lippard, S.J. & Essigmann, J. (1998) Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. Biochemistry 37, 352-362
11. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. U.S.A. 93, 6443-6447
12. Mello, J.A., Acharya, S., Fishel, R. & Essigmann, J.M. (1996) The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3, 579-589
13. Shellard, S.A., Hosking, L.K. & Hill, B.T. (1991) Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian cell lines in vitro. Cancer Res. 51, 4557-4564
14. Johnson, S.W., Laub, P.B., Beesley, J.S., Ozols, R.F. & Hamilton, T.C. (1997) Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res. 57, 850-856
15. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. (1993) p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967
16. Fan, S., El-Deiry, S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, Jr., A.J., Magrath, I., Kohn, K.W. & O'Connor, P.M. (1994) p53 Gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54, 5824-5830
17. Peng, H.-Q., Hogg, D., Malkin, D., Bailey, D., Gallie, B.L., Bulbul, M., Jewett, M., Buchanan, J. & Gross, P.E. (1993) Mutations of the p53 gene do not occur in testis cancer. Cancer Res. 53, 3574-3578
18. Chresta, C.M., Masters, J.R.W. & Hinkman, J.A. (1996) Hypersensitivity of human testicular tumours to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res. 56 1834-1841
19. Kelland, L.R., Murrer, B.A., Able, G., Giandomenico, C.M., Mistry, P. & Harrap, K.R. (1992) Ammine/amine platinum (IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res. 52, 822-828
20. Hollis, L.S., Amundsen, A.R. & Stern, E.W. (1989) Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumour agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+. J. Med. Chem. 32, 128-136
21. Rink, S.M., Yarema, K.J., Paige, L.A., Tadayoni, M., Solomon, M., Essigmann, J.M. & Croy, R.G. (1996) Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 93, 15063-15068